Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Other Non-Current Assets (2016 - 2026)

Apyx Medical filings provide 16 years of Other Non-Current Assets readings, the most recent being $1.8 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Assets rose 5.29% to $1.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.8 million, a 5.29% increase, with the full-year FY2025 number at $1.8 million, up 5.29% from a year prior.
  • Other Non-Current Assets hit $1.8 million in Q4 2025 for Apyx Medical, down from $1.8 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.9 million in Q2 2023 to a low of $860000.0 in Q1 2021.
  • Median Other Non-Current Assets over the past 5 years was $1.7 million (2024), compared with a mean of $1.5 million.
  • Biggest five-year swings in Other Non-Current Assets: surged 107.68% in 2021 and later dropped 6.39% in 2025.
  • Apyx Medical's Other Non-Current Assets stood at $1.1 million in 2021, then grew by 9.64% to $1.2 million in 2022, then surged by 42.32% to $1.7 million in 2023, then dropped by 3.93% to $1.7 million in 2024, then increased by 5.29% to $1.8 million in 2025.
  • The last three reported values for Other Non-Current Assets were $1.8 million (Q4 2025), $1.8 million (Q3 2025), and $1.7 million (Q2 2025) per Business Quant data.